AUG 07, 2017 09:00 AM PDT
Hemostasis and Women's Health: The Laboratory's Role in Diagnosing Complex Disorders
Presented at the Stago EdVantage Virtual University Virtual Event
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
7 34 3729

Speakers:
  • Scientific Market Development, Diagnostica Stago, Inc.
    Biography
      Dr. Mardovina has been employed by Diagnostica Stago, Inc. since October 3, 2016. As a Scientific Market Development team member, she is responsible for operational functions associated with scientific and market development activities for our North American Market. She engages with key opinion leaders, clinicians and researchers on scientific and marketing studies. She is currently involved in research project which is focusing on identifying coagulation parameters reference range at different stages of normal and complicated pregnancies.

      Dr. Mardovina was educated at the Grodno State Medical University in Belarus, where she earned her MD. She then completed a residency in pediatrics before enrolling at the National Scientific and Practical Center "Mother and Child" where she earned her PhD. Dr. Mardovina presented the findings from her research at international meetings and also produced several publications and patents. Her professional interest continuous to be focused on perinatal medicine.

    Abstract:

    Women have specific health needs due to acquired hypercoagulable states which occur during different phases of life.

    For example, women may be at risk of thrombosis during pregnancy and the postpartum period due to certain underlying genetic and acquired disease states. This presentation will provide an overview of potential thrombotic and bleeding disorders and how management and treatment are provided, with special focus paid to antiphospholipid syndrome (aPS) and disseminated intravascular coagulation (DIC).

    Learning Objectives

    1. Present overview of different disease states affecting women’s health, including venous thromboembolism, antiphospholipid syndrome, pregnancy related thrombocytopenia, and disseminated intravascular coagulation (DIC)

    2. Discuss clinical guidelines establishing best practices for laboratory diagnosis of these disorders

    3. Identify the role of the lupus anticoagulant (LA) relative to pathological thrombosis in clinical situations

    4. Explain case studies featuring women’s health disorders and laboratory diagnosis


    Show Resources
    Loading Comments...